Cargando…
Expert opinion on diagnosing, treating and managing patients with cerebrotendinous xanthomatosis (CTX): a modified Delphi study
BACKGROUND: Cerebrotendinous xanthomatosis (CTX) is a rare, chronic, progressive, neurodegenerative disorder requiring life-long care. Patients with CTX often experience a diagnostic delay. Although early diagnosis and treatment initiation can improve symptoms and prognosis, a standardised approach...
Autores principales: | Stelten, Bianca M. L., Dotti, Maria Teresa, Verrips, Aad, Elibol, Bülent, Falik-Zaccai, Tzipora C., Hanman, Kate, Mignarri, Andrea, Sithole, Belina, Steiner, Robert D., Verma, Surabhi, Yahalom, Gilad, Zubarioglu, Tanyel, Mochel, Fanny, Federico, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349076/ https://www.ncbi.nlm.nih.gov/pubmed/34362411 http://dx.doi.org/10.1186/s13023-021-01980-5 |
Ejemplares similares
-
The safety and effectiveness of chenodeoxycholic acid treatment in patients with cerebrotendinous xanthomatosis: two retrospective cohort studies
por: Verrips, Aad, et al.
Publicado: (2019) -
Cerebrotendinous xanthomatosis‐associated diarrhea and response to chenodeoxycholic acid treatment
por: Brass, Eric P., et al.
Publicado: (2020) -
Cerebrotendinous xanthomatosis
por: Vadapalli, Satyadev
Publicado: (2013) -
Cerebrotendinous xanthomatosis
por: Muniaswamy, Mahalakshmi, et al.
Publicado: (2016) -
Evaluation of the effect of chenodeoxycholic acid treatment on skeletal system findings in patients with cerebrotendinous xanthomatosis
por: Zübarioğlu, Tanyel, et al.
Publicado: (2019)